CN105476953B - 一种用于补铁的液体制剂及其制备方法 - Google Patents
一种用于补铁的液体制剂及其制备方法 Download PDFInfo
- Publication number
- CN105476953B CN105476953B CN201510547247.XA CN201510547247A CN105476953B CN 105476953 B CN105476953 B CN 105476953B CN 201510547247 A CN201510547247 A CN 201510547247A CN 105476953 B CN105476953 B CN 105476953B
- Authority
- CN
- China
- Prior art keywords
- iron
- preparation
- solution
- liquid preparation
- mass percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title claims abstract description 180
- 238000002360 preparation method Methods 0.000 title claims abstract description 108
- 229910052742 iron Inorganic materials 0.000 title claims abstract description 90
- 239000007788 liquid Substances 0.000 title claims abstract description 85
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 24
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 16
- GIPOFCXYHMWROH-UHFFFAOYSA-L 2-aminoacetate;iron(2+) Chemical compound [Fe+2].NCC([O-])=O.NCC([O-])=O GIPOFCXYHMWROH-UHFFFAOYSA-L 0.000 claims abstract description 14
- 239000013522 chelant Substances 0.000 claims abstract description 14
- 229940086413 ferrous bisglycinate Drugs 0.000 claims abstract description 14
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims abstract description 8
- 108010011485 Aspartame Proteins 0.000 claims abstract description 8
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229920001100 Polydextrose Polymers 0.000 claims abstract description 8
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000605 aspartame Substances 0.000 claims abstract description 8
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims abstract description 8
- 229960003438 aspartame Drugs 0.000 claims abstract description 8
- 235000010357 aspartame Nutrition 0.000 claims abstract description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 8
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 8
- 239000001259 polydextrose Substances 0.000 claims abstract description 8
- 229940035035 polydextrose Drugs 0.000 claims abstract description 8
- 235000013856 polydextrose Nutrition 0.000 claims abstract description 8
- 239000004302 potassium sorbate Substances 0.000 claims abstract description 8
- 229940069338 potassium sorbate Drugs 0.000 claims abstract description 8
- 235000010241 potassium sorbate Nutrition 0.000 claims abstract description 8
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims abstract description 8
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims abstract description 8
- 230000000295 complement effect Effects 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims description 38
- 230000001954 sterilising effect Effects 0.000 claims description 19
- 239000011259 mixed solution Substances 0.000 claims description 12
- 238000007689 inspection Methods 0.000 claims description 11
- 239000011790 ferrous sulphate Substances 0.000 claims description 8
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 8
- 238000011049 filling Methods 0.000 claims description 8
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 8
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 8
- 229940098462 oral drops Drugs 0.000 claims description 7
- 238000012797 qualification Methods 0.000 claims description 7
- 238000010792 warming Methods 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- BTIJJDXEELBZFS-UHFFFAOYSA-K hemin Chemical compound [Cl-].[Fe+3].[N-]1C(C=C2C(=C(C)C(C=C3C(=C(C)C(=C4)[N-]3)C=C)=N2)C=C)=C(C)C(CCC(O)=O)=C1C=C1C(CCC(O)=O)=C(C)C4=N1 BTIJJDXEELBZFS-UHFFFAOYSA-K 0.000 claims description 2
- 230000036541 health Effects 0.000 abstract description 8
- 230000035943 smell Effects 0.000 abstract description 5
- 235000020995 raw meat Nutrition 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 description 26
- 208000007502 anemia Diseases 0.000 description 20
- 238000002474 experimental method Methods 0.000 description 19
- 241000700159 Rattus Species 0.000 description 18
- 210000003743 erythrocyte Anatomy 0.000 description 14
- 102000001554 Hemoglobins Human genes 0.000 description 13
- 108010054147 Hemoglobins Proteins 0.000 description 13
- 239000013641 positive control Substances 0.000 description 9
- 235000013361 beverage Nutrition 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 206010022971 Iron Deficiencies Diseases 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 229940100688 oral solution Drugs 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 5
- 229950003776 protoporphyrin Drugs 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 206010057315 Daydreaming Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000019505 Deglutition disease Diseases 0.000 description 2
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 2
- 102000008857 Ferritin Human genes 0.000 description 2
- 108050000784 Ferritin Proteins 0.000 description 2
- 238000008416 Ferritin Methods 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000009098 adjuvant therapy Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000014106 fortified food Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000041 toxicology testing Toxicity 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 102000008133 Iron-Binding Proteins Human genes 0.000 description 1
- 108010035210 Iron-Binding Proteins Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 240000003186 Stachytarpheta cayennensis Species 0.000 description 1
- 235000009233 Stachytarpheta cayennensis Nutrition 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000021336 beef liver Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000002242 deionisation method Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 235000000396 iron Nutrition 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 238000009206 nuclear medicine Methods 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- -1 potassium ferricyanide Chemical compound 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000009692 water atomization Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510547247.XA CN105476953B (zh) | 2015-09-01 | 2015-09-01 | 一种用于补铁的液体制剂及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510547247.XA CN105476953B (zh) | 2015-09-01 | 2015-09-01 | 一种用于补铁的液体制剂及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105476953A CN105476953A (zh) | 2016-04-13 |
| CN105476953B true CN105476953B (zh) | 2018-10-30 |
Family
ID=55664472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510547247.XA Active CN105476953B (zh) | 2015-09-01 | 2015-09-01 | 一种用于补铁的液体制剂及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105476953B (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114073316A (zh) * | 2021-11-22 | 2022-02-22 | 中国农业大学 | 一种驴脾蛋白补铁口服液及其制备方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1443541A (zh) * | 2003-04-12 | 2003-09-24 | 新疆特丰药业股份有限公司 | 阿胶铁口服液及其生产方法 |
| CN101129351A (zh) * | 2006-08-25 | 2008-02-27 | 内蒙古百金纳投资有限责任公司 | 一种补铁剂组合物,其制备方法和应用 |
| CN101904507A (zh) * | 2009-06-04 | 2010-12-08 | 上海久健生物科技发展有限公司 | 甘氨酸亚铁营养组合物及其应用 |
| CN101987113A (zh) * | 2009-07-30 | 2011-03-23 | 天津瑞普生物技术股份有限公司 | 一种增稠且稳定的动物补铁组合物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060134227A1 (en) * | 2004-12-22 | 2006-06-22 | Bortz Jonathan D | Compositions including iron |
-
2015
- 2015-09-01 CN CN201510547247.XA patent/CN105476953B/zh active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1443541A (zh) * | 2003-04-12 | 2003-09-24 | 新疆特丰药业股份有限公司 | 阿胶铁口服液及其生产方法 |
| CN101129351A (zh) * | 2006-08-25 | 2008-02-27 | 内蒙古百金纳投资有限责任公司 | 一种补铁剂组合物,其制备方法和应用 |
| CN101904507A (zh) * | 2009-06-04 | 2010-12-08 | 上海久健生物科技发展有限公司 | 甘氨酸亚铁营养组合物及其应用 |
| CN101987113A (zh) * | 2009-07-30 | 2011-03-23 | 天津瑞普生物技术股份有限公司 | 一种增稠且稳定的动物补铁组合物 |
Non-Patent Citations (1)
| Title |
|---|
| "复方锌铁钙口服液生产工艺的研究";王丽等;《北方药学》;20101231;第7卷(第1期);第21-23页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105476953A (zh) | 2016-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104857030A (zh) | 一种灵芝孢子粉的破壁方法及使用该方法得到的产品 | |
| Taylor et al. | Influence of diet on iron, copper, and zinc status in children under 24 months of age | |
| CN102565052A (zh) | 一种检测食品中亚硝酸盐含量的快速检测试剂盒及应用 | |
| CN105476953B (zh) | 一种用于补铁的液体制剂及其制备方法 | |
| CN105754817A (zh) | 一种具有改善睡眠功能的保健酒及制备方法 | |
| Banerjee et al. | Detoxification of Nerium indicum roots based on Indian system of medicine: Phytochemical and toxicity evaluations | |
| CN105595346B (zh) | 一种用于补钙的液体制剂及其制备方法 | |
| CN103550398A (zh) | 一种缓解疲劳的组合物及其制备方法和医药用途 | |
| CN109999088A (zh) | 一种具有润肠通便功效的复方制剂及其应用 | |
| CN106310034B (zh) | 一种增加骨密度的药物组合物及其制备方法 | |
| CN110327411A (zh) | 乌发组合物 | |
| US20190159483A1 (en) | Solid Drink for Regulating Qi-depression Constitution and Processing Method thereof | |
| CN108175825A (zh) | 用于补肾益气,健脾润肺的药物组合物及其制备方法 | |
| KR100584888B1 (ko) | 장어와 한방생약을 주재료로 하는 강정음료 및 이의제조방법 | |
| AU2001262699B2 (en) | Biologically active agents and drugs | |
| Failla et al. | Total body content of copper and other essential metals in rats fed fructose or starch | |
| CN109430667A (zh) | 一种具有降尿酸作用的组合物及固体饮料 | |
| CN102205083B (zh) | 用于治疗痛风的黄嘌呤氧化酶抑制剂及其制备方法 | |
| KR920010325B1 (ko) | 약용꿀의 제조방법 | |
| WO2018222164A2 (en) | Use of an herbal formula containing pumpkin seed oil in bph treatment | |
| CN109172730A (zh) | 一种具有改善更年期综合症功能的组合物及其制备方法与应用 | |
| CN109350691A (zh) | 一种中药排镉益肾生精膏及其制备方法 | |
| TWI274551B (en) | Nutriment recipe containing extract of grape seeds | |
| Thudichum | A manual of chemical physiology, including its points of contact with pathology | |
| CN107982513A (zh) | 一种盐藻地龙蛋白复方保健品及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DD01 | Delivery of document by public notice |
Addressee: Zhang Wei Document name: Notification to Make Rectification |
|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190404 Address after: 110 meters north of Xiaoying Village Committee, Liangxiang Township, Fangshan District, Beijing Patentee after: Lianlui Huikang (Beijing) Technology Development Co.,Ltd. Address before: Room 302, Building 1, Gongxing Garden, Liangxiang, Fangshan District, Beijing Patentee before: Zhang Wei |
|
| CI03 | Correction of invention patent | ||
| CI03 | Correction of invention patent |
Correction item: Patentee|Address Correct: Congrui Huikang (Beijing) Technology Development Co., Ltd.|110 meters north of Xiaoying Village Committee, Liangxiang Township, Fangshan District, Beijing False: Lianlui Huikang (Beijing) Technology Development Co., Ltd.|110 meters north of Xiaoying Village Committee, Liangxiang Township, Fangshan District, Beijing Number: 17-01 Volume: 35 |